Tremor
TrialsCompaniesTrack record

Not investment advice.

Tremor shows what changed in public records. It never tells anyone to buy or sell. Many trial edits are harmless paperwork. Data from ClinicalTrials.gov, the SEC, and the Federal Register.

Track recordPrivacyTerms

AMGNAmgenRunning, no new patients

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Limited Stage Small Cell Lung Cancer · Small Cell Lung Cancer

2Calmworry score, out of 100

No strong warning signs right now. The score counts warning signs; it is not a prediction.

Why this score

  • 3 insiders sold shares within a month

    Since Aug 13, 2026 · was worth 5, fading over time

    +1.8
Worry score2

Score over time

Upside and downside

What happened after similar warning signs in the past. This is history, not a prediction.

  • Several insiders sold shares

    We don't have enough past cases yet to say how often bad news followed when several insiders sold shares. Tremor started recording trial records on Nov 6, 2026 and builds this history as it goes.

How big a deal for them
Lower. It's one of 35 late-stage cancer trials we track for this big company, so one trial usually matters less to its stock.
Money left
It isn't burning cash right now. Details
When we'll find out
Main results are expected around Apr 20, 2030.

Past cases come from public records since 2016 for companies still listed today. Companies that went out of business aren't included, which may make past outcomes look a little better than they were.

See every past case on the track record page

Stage
Phase 3
Patients
404 (final count)
Started
Feb 20, 2024
Main results expected
Apr 20, 2030
Fully finished
Apr 20, 2030
Results posted
not yet

What counts as success

The trial's main goal(s), called the “primary outcome.”

  • PFS as Determined by BICR

    Measured over: Up to approximately 6 years

  • OS Over the Whole Trial

    Measured over: Up to approximately 6 years

Changes Tremor has spotted

No changes since Tremor started watching this trial.

Ask about this trial

Answers use only Tremor's data about this trial, written by AI. Not investment advice.

Show details (technical version)

Score inputs

  • insider_selling_cluster: base 5, now 1.8, since 2026-08-13, fades (half-life)

Raw record changes

  • none yet

Trial ID NCT06117774 · record last updated 2026-04-29 · checked 2026-11-10 12:40 UTC

See the official record on ClinicalTrials.gov (NCT06117774) ↗